Correlation Between Avalo Therapeutics and AnaptysBio

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Avalo Therapeutics and AnaptysBio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Avalo Therapeutics and AnaptysBio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Avalo Therapeutics and AnaptysBio, you can compare the effects of market volatilities on Avalo Therapeutics and AnaptysBio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Avalo Therapeutics with a short position of AnaptysBio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Avalo Therapeutics and AnaptysBio.

Diversification Opportunities for Avalo Therapeutics and AnaptysBio

-0.7
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Avalo and AnaptysBio is -0.7. Overlapping area represents the amount of risk that can be diversified away by holding Avalo Therapeutics and AnaptysBio in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on AnaptysBio and Avalo Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Avalo Therapeutics are associated (or correlated) with AnaptysBio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of AnaptysBio has no effect on the direction of Avalo Therapeutics i.e., Avalo Therapeutics and AnaptysBio go up and down completely randomly.

Pair Corralation between Avalo Therapeutics and AnaptysBio

Given the investment horizon of 90 days Avalo Therapeutics is expected to generate 5.68 times more return on investment than AnaptysBio. However, Avalo Therapeutics is 5.68 times more volatile than AnaptysBio. It trades about 0.03 of its potential returns per unit of risk. AnaptysBio is currently generating about 0.03 per unit of risk. If you would invest  4,800  in Avalo Therapeutics on August 26, 2024 and sell it today you would lose (3,787) from holding Avalo Therapeutics or give up 78.9% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthWeak
Accuracy100.0%
ValuesDaily Returns

Avalo Therapeutics  vs.  AnaptysBio

 Performance 
       Timeline  
Avalo Therapeutics 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Avalo Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Avalo Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
AnaptysBio 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days AnaptysBio has generated negative risk-adjusted returns adding no value to investors with long positions. Despite inconsistent performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors.

Avalo Therapeutics and AnaptysBio Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Avalo Therapeutics and AnaptysBio

The main advantage of trading using opposite Avalo Therapeutics and AnaptysBio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Avalo Therapeutics position performs unexpectedly, AnaptysBio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in AnaptysBio will offset losses from the drop in AnaptysBio's long position.
The idea behind Avalo Therapeutics and AnaptysBio pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.

Other Complementary Tools

Transaction History
View history of all your transactions and understand their impact on performance
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Stock Screener
Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume